Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Nanowired delivery of DL-3-n-butylphthalide induces superior neuroprotection in concussive head injury.

Niu F, Sharma A, Feng L, Ozkizilcik A, Muresanu DF, Lafuente JV, Tian ZR, Nozari A, Sharma HS.

Prog Brain Res. 2019;245:89-118. doi: 10.1016/bs.pbr.2019.03.008. Epub 2019 Apr 2.

PMID:
30961873
2.

TiO2-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury.

Feng L, Sharma A, Niu F, Huang Y, Lafuente JV, Muresanu DF, Ozkizilcik A, Tian ZR, Sharma HS.

Mol Neurobiol. 2018 Jan;55(1):350-358. doi: 10.1007/s12035-017-0746-5.

PMID:
28856586
3.

Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nanowired delivery of cerebrolysin with α-melanocyte-stimulating hormone.

Sharma A, Muresanu DF, Ozkizilcik A, Tian ZR, Lafuente JV, Manzhulo I, Mössler H, Sharma HS.

Prog Brain Res. 2019;245:1-55. doi: 10.1016/bs.pbr.2019.03.002. Epub 2019 Apr 2.

PMID:
30961865
4.

Nanowired drug delivery to enhance neuroprotection in spinal cord injury.

Tian ZR, Sharma A, Nozari A, Subramaniam R, Lundstedt T, Sharma HS.

CNS Neurol Disord Drug Targets. 2012 Feb;11(1):86-95. Review.

PMID:
22385571
6.

Nanowired drug delivery of antioxidant compound H-290/51 enhances neuroprotection in hyperthermia-induced neurotoxicity.

Muresanu DF, Sharma A, Tian ZR, Smith MA, Sharma HS.

CNS Neurol Disord Drug Targets. 2012 Feb;11(1):50-64. Review.

PMID:
22229325
7.

Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease.

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Tian ZR, Ozkizilcik A, Manzhulo I, Mössler H, Sharma A.

Prog Brain Res. 2019;245:145-200. doi: 10.1016/bs.pbr.2019.03.009. Epub 2019 Apr 2.

PMID:
30961867
8.

Dl-3-n-Butylphthalide (NBP): A Promising Therapeutic Agent for Ischemic Stroke.

Wang S, Ma F, Huang L, Zhang Y, Peng Y, Xing C, Feng Y, Wang X, Peng Y.

CNS Neurol Disord Drug Targets. 2018;17(5):338-347. doi: 10.2174/1871527317666180612125843.

PMID:
29895257
9.

DL-3-n-Butylphthalide (NBP) Provides Neuroprotection in the Mice Models After Traumatic Brain Injury via Nrf2-ARE Signaling Pathway.

Liu Z, Wang H, Shi X, Li L, Zhou M, Ding H, Yang Y, Li X, Ding K.

Neurochem Res. 2017 May;42(5):1375-1386. doi: 10.1007/s11064-017-2186-z. Epub 2017 Feb 18.

PMID:
28214984
10.

Poly (D,L-lactide-co-glycolide) nanoparticles loaded with cerebrolysin display neuroprotective activity in a rat model of concussive head injury.

Ruozi B, Belletti D, Forni F, Sharma A, Muresanu D, Mössler H, Vandelli MA, Tosi G, Sharma HS.

CNS Neurol Disord Drug Targets. 2014;13(8):1475-82.

PMID:
25106629
11.

Application and prospects of butylphthalide for the treatment of neurological diseases.

Chen XQ, Qiu K, Liu H, He Q, Bai JH, Lu W.

Chin Med J (Engl). 2019 May 13. doi: 10.1097/CM9.0000000000000289. [Epub ahead of print]

PMID:
31107716
12.

A Systematic Review of Neuroprotective Efficacy and Safety of DL-3-N-Butylphthalide in Ischemic Stroke.

Xu ZQ, Zhou Y, Shao BZ, Zhang JJ, Liu C.

Am J Chin Med. 2019 Apr 9:1-19. doi: 10.1142/S0192415X19500265. [Epub ahead of print]

PMID:
30966774
13.

dl-3-n-butylphthalide for alleviation of neurological deficit after combined extracranial-intracranial revascularization for moyamoya disease: a propensity score-matched analysis.

Li Z, Lu J, Ma L, Wu C, Xu Z, Chen X, Ye X, Wang R, Zhao Y.

J Neurosurg. 2019 Feb 15:1-13. doi: 10.3171/2018.10.JNS182152. [Epub ahead of print]

PMID:
30771781
14.

DL-3-n-butylphthalide induced neuroprotection, regenerative repair, functional recovery and psychological benefits following traumatic brain injury in mice.

Zhao Y, Lee JH, Chen D, Gu X, Caslin A, Li J, Yu SP, Wei L.

Neurochem Int. 2017 Dec;111:82-92. doi: 10.1016/j.neuint.2017.03.017. Epub 2017 Mar 28.

15.

dl-3-n-butylphthalide reduces brain damage in mice with closed head injury.

Chong Z, Feng Y.

Chin Med J (Engl). 2000 Jul;113(7):613-6.

PMID:
11776030
16.

Dl-3-n-butylphthalide improves functional recovery in rats with spinal cord injury by inhibiting endoplasmic reticulum stress-induced apoptosis.

He Z, Zhou Y, Huang Y, Wang Q, Zheng B, Zhang H, Li J, Liu Y, Wu F, Zhang X, Tong S, Wang M, Wang Z, He H, Xu H, Xiao J.

Am J Transl Res. 2017 Mar 15;9(3):1075-1087. eCollection 2017.

17.

Dl-3-n-butylphthalide prevents the disruption of blood-spinal cord barrier via inhibiting endoplasmic reticulum stress following spinal cord injury.

Zheng B, Zhou Y, Zhang H, Yang G, Hong Z, Han D, Wang Q, He Z, Liu Y, Wu F, Zhang X, Tong S, Xu H, Xiao J.

Int J Biol Sci. 2017 Nov 27;13(12):1520-1531. doi: 10.7150/ijbs.21107. eCollection 2017.

18.

Novel Treatment Strategies Using TiO2-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease.

Sharma A, Menon PK, Patnaik R, Muresanu DF, Lafuente JV, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma HS.

Int Rev Neurobiol. 2017;137:123-165. doi: 10.1016/bs.irn.2017.09.002. Epub 2017 Nov 6. Review.

PMID:
29132541
19.

Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease.

Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS.

Prog Brain Res. 2019;245:201-246. doi: 10.1016/bs.pbr.2019.03.014. Epub 2019 Apr 2.

PMID:
30961868
20.

Supplemental Content

Support Center